·威勒布兰德病是一种疾病.
Omid Seidizadeh1, Jeroen C J Eikenboom2, Cécile V Denis3
1Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Nature reviews. Disease primers
|July 25, 2024
概括
·维莱布兰德病 (VWD) 是一种常见的遗传性出血疾病,由·维莱布兰德因子缺陷引起. 由于复杂的症状和潜在的误诊,准确的诊断和管理至关重要.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 内部医学 内部医学
背景情况:
- ·威尔布兰德病 (VWD) 是最常见的遗传性出血障碍,其特点是粘膜皮肤出血过多.
- 冠状动脉疾病是由·维勒布兰德因子 (VWF) 糖蛋白的定量或质量缺陷引起的,导致各种亚型 (类型1,2A,2B,2M,2N和3).
- 在VWD诊断方面的挑战包括症状的变化,影响VWF水平的外部因素,以及医疗保健提供者的有限认识.
研究的目的:
- 提供关于·威尔布兰德病 (VWD) 的全面概述.
- 为了突出诊断和管理这种常见的遗传性出血障碍的复杂性.
- 强调专业诊断方法和治疗策略的重要性.
主要方法:
- 审查VWD病理生理学,分类和临床表现.
- 讨论诊断方法,包括表型检测和遗传检测.
- 目前管理策略的概述,包括德斯莫普林素,VWF缩剂和辅助疗法.
主要成果:
- VWD呈现出多样化的出血症状,从表和伤到流血和手术出血.
- 定量VWF缺陷导致1型和3型VWD,而定性缺陷定义了2型VWD.
- 由于VWD的复杂性和影响因素,准确的诊断需要专门的测试.
结论:
- 有效的VWD管理涉及VWF水平的增强 (desmopressin或缩剂) 和辅助治疗.
- 解决诊断挑战和提高疾病意识对于最佳的患者护理至关重要.
- 对VWF病理生理学和治疗的持续研究对于改善VWD患者的治疗结果至关重要.
相关概念视频
Disorders of Hemostasis
795
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
795
Formation of the Platelet Plug
5.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
663
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
663
Extrinsic and Intrinsic Pathways of Hemostasis
6.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.9K
Introduction to Hemostasis
7.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.0K
Coagulation
6.0K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.0K


